Cargando…

Autosomal recessive Alport syndrome caused by a novel COL4A4 splice site mutation: a case report

Detalles Bibliográficos
Autores principales:	Šenjug, Petar, Nikuševa Martić, Tamara, Šenjug Perica, Marija, Oroz, Maja, Horaček, Matija, Ćuk, Martin, Abdović, Slaven, Galešić Ljubanović, Danica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852137/ https://www.ncbi.nlm.nih.gov/pubmed/31686460 http://dx.doi.org/10.3325/cmj.2019.60.458

Ejemplares similares

Clinical and pathohistological characteristics of Alport spectrum disorder caused by COL4A4 mutation c.193-2A>C: a case series
por: Šenjug, Petar, et al.
Publicado: (2021)

Clinical and histopathological characteristics of COL4A3 c.2881+1G>A variant causing Alport spectrum disorders in Croatian population
por: Horaček, Matija, et al.
Publicado: (2023)

Immune-mediated diseases after coronavirus disease 2019 vaccination: rare but important complication
por: Zagorec, Nikola, et al.
Publicado: (2022)

Resistant and Relapsing Collapsing Glomerulopathy Successfully Treated with Rituximab—A Case Report
por: Zagorec, Nikola, et al.
Publicado: (2022)

Letter to the Editor: Characterization of Choriocapillaris and Choroidal Abnormalities in Alport Syndrome
por: Bosnar, Damir, et al.
Publicado: (2023)

Crescentic Glomerulonephritis Due to Enterococcal Endocarditis
por: Klarić, Dragan, et al.
Publicado: (2023)

PULMONARY HEMORRHAGE AND CRESCENTIC GLOMERULONEPHRITIS IN A PATIENT WITH SEROPOSITIVE ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE AND ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES
por: Sreter, Katherina Bernadette, et al.
Publicado: (2022)

COL4A6 is dispensable for autosomal recessive Alport syndrome
por: Murata, Tomohiro, et al.
Publicado: (2016)

De novo immune complex–mediated membranoproliferative glomerulonephritis after COVID-19 vaccination
por: Zagorec, Nikola, et al.
Publicado: (2023)

IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis
por: Pačić, Arijana, et al.
Publicado: (2017)

Potential Founder Variants in COL4A4 Identified in Bukharian Jews Linked to Autosomal Dominant and Autosomal Recessive Alport Syndrome
por: Levy, Michal, et al.
Publicado: (2023)

Genotype-Phenotype Correlations for Pathogenic COL4A3–COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2022)

A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome
por: Odiatis, Christoforos, et al.
Publicado: (2020)

A founder COL4A4 pathogenic variant resulting in autosomal recessive Alport syndrome accounts for most genetic kidney failure in Romani people
por: Plevova, Pavlina, et al.
Publicado: (2023)

Efficacy of Dapagliflozin in Adult Autosomal Recessive Alport Syndrome
por: Song, Zhuo-ran, et al.
Publicado: (2022)

Pregnancy in women with autosomal recessive Alport syndrome caused by novel compound heterozygous mutations of COL4A3 gene: Two cases reports
por: Gao, Xiaoli, et al.
Publicado: (2023)

Features of Autosomal Recessive Alport Syndrome: A Systematic Review
por: Lee, Jiwon M., et al.
Publicado: (2019)

Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant?
por: Savige, Judy
Publicado: (2018)

COL4A1-related autosomal recessive encephalopathy in 2 Turkish children
por: Yaramis, Ahmet, et al.
Publicado: (2020)

Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome
por: Liu, Jian-Hong, et al.
Publicado: (2017)

A patient with autosomal recessive Alport syndrome due to segmental maternal isodisomy
por: Fu, Xue J, et al.
Publicado: (2014)

Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome
por: Cerkauskaite, Agne, et al.
Publicado: (2022)

Heterozygous Pathogenic COL4A3 and COL4A4 Variants (Autosomal Dominant Alport Syndrome) Are Common, and Not Typically Associated With End-Stage Kidney Failure, Hearing Loss, or Ocular Abnormalities
por: Savige, Judy
Publicado: (2022)

Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X‐linked Alport syndrome
por: Zhang, Yanqin, et al.
Publicado: (2019)

Genotype–phenotype correlations and nephroprotective effects of RAAS inhibition in patients with autosomal recessive Alport syndrome
por: Zhang, Yanqin, et al.
Publicado: (2021)

Genotype–phenotype correlations for COL4A3–COL4A5 variants resulting in Gly substitutions in Alport syndrome
por: Gibson, Joel T., et al.
Publicado: (2022)

X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations
por: Savige, Judith, et al.
Publicado: (2016)

Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport Syndrome using next generation sequence technique
por: Zhao, Xuechao, et al.
Publicado: (2019)

Trimerization and Genotype–Phenotype Correlation of COL4A5 Mutants in Alport Syndrome
por: Kamura, Misato, et al.
Publicado: (2020)

Identification of a novel collagen type IV alpha-4 (COL4A4) mutation in a Chinese family with autosomal dominant Alport syndrome using exome sequencing
por: Deng, Sheng, et al.
Publicado: (2016)

Novel heterozygous mutation in COL4A4 responsible for Alport syndrome in a Chinese family
por: Du, Ran, et al.
Publicado: (2022)

New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells
por: Daga, Sergio, et al.
Publicado: (2019)

Clinical Manifestations of Alport Syndrome-Diffuse Leiomyomatosis Patients With Contiguous Gene Deletions in COL4A6 and COL4A5
por: Zhou, Xi, et al.
Publicado: (2021)

Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
por: Savige, Judy, et al.
Publicado: (2021)

The 2019 and 2021 International Workshops on Alport Syndrome
por: Daga, Sergio, et al.
Publicado: (2022)

Creation of X-linked Alport syndrome rat model with Col4a5 deficiency
por: Namba, Masumi, et al.
Publicado: (2021)

The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome
por: Yamamura, Tomohiko, et al.
Publicado: (2022)

Case Report: Identification of a Novel Heterozygous Missense Mutation in COL4A3 Gene Causing Variable Phenotypes in an Autosomal-Dominant Alport Syndrome Family
por: Hu, Yanglin, et al.
Publicado: (2022)

Alport syndrome caused by a COL4A5 deletion and exonization of an adjacent AluY
por: Nozu, Kandai, et al.
Publicado: (2014)

New Insights into Renal Failure in a Cohort of 317 Patients with Autosomal Dominant Forms of Alport Syndrome: Report of Two Novel Heterozygous Mutations in COL4A3
por: García-Aznar, José María, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_am7dja4j75giukerfm9g2ceq8j